Digital Health Technology Assessment – Challenges and opportunities ... Changes to Health Technology Assessment in Europe offer new opportunities to streamline processes and get innovative treatments to market faster
R&D Partner Content 3rd World ADC Asia Optimising Physiochemical, Potency & Impurity Analytical Methods to Ensure Regulatory Compliance
R&D Partner Content CRISPR-Based Therapy Analytical Development Summit CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products.
Oncology In pursuit of a cure for cancer: An ASCO 2025 discussion wit... Dr Danny Nguyen, medical oncologist and haematologist at the City of Hope Orange County, spoke with pharmaphorum at ASCO 2025.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face